Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Federal Court finds insufficient evidence Roundup weedkiller causes cancer. What does the science say?
Ian Musgrave, University of Adelaide A major Federal Court class action has been dismissed this…
Study identifies biomarker that could predict whether colon cancer patients benefit from chemotherapy
Many people with stage II or III colon cancer receive additional, or adjuvant, chemotherapy following…
Why the most prescribed chemotherapy drug can cause serious heart damage
There’s still much to learn about how doxorubicin, a 50-year-old chemotherapy drug, causes its most…
The Recapture Life Trial results: Busting a few myths about young people and online survivorship support
Not long ago, it would have been impossible to predict the way in which the COVID-19 pandemic would force the…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.